Eian Kantor

Uncontrolled movements in Parkinson's disease

Parkinson's disease is a disorder that can involve several different kinds of uncontrolled movements. Some are caused by the disease, such as tremor and gait freezing, while dyskinesia – uncontrolled jerking or twisting movement – is caused by long-term levodopa use. We unpack how dyskinesia affects movement in Parkinson’s disease and how it’s usually treated.

Continue reading

Common questions about lupus clinical trials

Clinical trials for lupus are investigating potential treatments and need volunteers to take part. The research process can be confusing, though. If you're interested in finding a lupus clinical trial but don't know where to start, we've collected a list of some of the most common questions patients ask about research participation.

Continue reading

How we achieved a 63% randomization rate for a recent myasthenia gravis recruitment project [case study]

Myasthenia gravis (MG) is a rare condition that affects approximately 36,000 to 60,000 individuals in the United States. Even though there are a variety of treatment options, it can be difficult to predict symptom flare-ups. Creative approaches are necessary to provide the best outcomes for patients.

Continue reading

4 things to know about primary biliary cholangitis (PBC)

Primary biliary cholangitis (PBC), formerly known as primary biliary cirrhosis, is a chronic autoimmune disease. Researchers estimate that about 65 out of every 100,000 women in the United States have PBC; this number is much lower in men. When a person has PBC, the immune system attacks the small bile ducts, which can cause damage to the liver.

Continue reading

Three ways to connect with your community if you have a rare disease

In the United States, there are an estimated 25-30 million individuals living with a rare disease, which is defined as a condition that affects fewer than 200,000 people in the US.

Continue reading

6 smart clinical trial patient recruitment strategies

Clinical trial recruitment is critical to the success of your trial, and developing a strategy in advance is key to saving time and money as enrollment ramps up. The best clinical trial recruitment strategies start with a thorough assessment of the trial protocol, the desired patient population, and where you predict challenges might arise. Then, make sure you have a variety of tools at your ...

Continue reading

5 common clinical trial patient recruitment strategy mistakes

It can be frustrating to plan out a detailed clinical trial patient recruitment strategy only to have something not quite click. There are a few common mistakes recruiters make in the planning stage that can cause problems down the road — if you're not getting the results you're looking for, it's possible that you've made one of these errors.

Continue reading

7 Alzheimer's disease myths and facts

Anyone who has a loved one living with Alzheimer’s disease is very much aware of the disease and its challenges, but there are still several misconceptions about Alzheimer’s symptoms, diagnosis, and treatments.

Continue reading

5 clinical trial advertising services to boost recruitment

Clinical trial recruitment companies offer a range of advertising services that can help speed up enrollment for your trial. While some trial sponsors, research sites, and Contract Research Organizations (CROs) opt for full-service offerings from recruitment agencies, you may also choose support for a particular element of your campaign.

Continue reading

How long before levodopa stops working in Parkinson’s disease?

Carbidopa-levodopa is a drug combination that works to reduce symptoms in Parkinson's disease for as long as a patient takes it. Put simply, levodopa converts into dopamine in the brain, helping to control movement, while carbidopa prevents the breakdown of levodopa in the bloodstream so more levodopa can enter the brain. Carbidopa can also reduce nausea and vomiting, common levodopa side ...

Continue reading

Get our latest posts in your inbox